BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 35480230)

  • 1. γδ T cell costimulatory ligands in antitumor immunity.
    McGraw JM; Witherden DA
    Explor Immunol; 2022; 2(1):79-97. PubMed ID: 35480230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hspa8 and ICAM-1 as damage-induced mediators of γδ T cell activation.
    Johnson MD; Otuki MF; Cabrini DA; Rudolph R; Witherden DA; Havran WL
    J Leukoc Biol; 2022 Jan; 111(1):135-145. PubMed ID: 33847413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coreceptors and Their Ligands in Epithelial γδ T Cell Biology.
    Witherden DA; Johnson MD; Havran WL
    Front Immunol; 2018; 9():731. PubMed ID: 29686687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic Epidermal T Cells in Allergic Contact Dermatitis.
    Mraz V; Geisler C; Bonefeld CM
    Front Immunol; 2020; 11():874. PubMed ID: 32508820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy.
    Liu Y; Zhang C
    Cells; 2020 May; 9(5):. PubMed ID: 32413966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7-CD28 costimulatory signals control the survival and proliferation of murine and human γδ T cells via IL-2 production.
    Ribot JC; Debarros A; Mancio-Silva L; Pamplona A; Silva-Santos B
    J Immunol; 2012 Aug; 189(3):1202-8. PubMed ID: 22732586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of intercellular adhesion molecule (ICAM)-1 or ICAM-2 is critical in determining sensitivity of pancreatic cancer cells to cytolysis by human gammadelta-T cells: implications in the design of gammadelta-T-cell-based immunotherapies for pancreatic cancer.
    Liu Z; Guo B; Lopez RD
    J Gastroenterol Hepatol; 2009 May; 24(5):900-11. PubMed ID: 19175829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovine skin-recirculating γδ T cells express IFN-γ and IL-17 and exit tissue independently of CCR7.
    Geherin SA; Lee MH; Wilson RP; Debes GF
    Vet Immunol Immunopathol; 2013 Sep; 155(1-2):87-97. PubMed ID: 23838472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five Layers of Receptor Signaling in γδ T-Cell Differentiation and Activation.
    Ribeiro ST; Ribot JC; Silva-Santos B
    Front Immunol; 2015; 6():15. PubMed ID: 25674089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Advances in γδ T Cell-Based Tumor Immunotherapy.
    Lo Presti E; Pizzolato G; Gulotta E; Cocorullo G; Gulotta G; Dieli F; Meraviglia S
    Front Immunol; 2017; 8():1401. PubMed ID: 29163482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin Resident γδ T Cell Function and Regulation in Wound Repair.
    Munoz LD; Sweeney MJ; Jameson JM
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All hands on DE(T)C: Epithelial-resident γδ T cells respond to tissue injury.
    Ramirez K; Witherden DA; Havran WL
    Cell Immunol; 2015 Jul; 296(1):57-61. PubMed ID: 25958272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Vδ2 versus non-Vδ2 γδ T cells in antitumor immunity.
    Kabelitz D; Kalyan S; Oberg HH; Wesch D
    Oncoimmunology; 2013 Mar; 2(3):e23304. PubMed ID: 23802074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD122-directed interleukin-2 treatment mechanisms in bladder cancer differ from αPD-L1 and include tissue-selective γδ T cell activation.
    Reyes RM; Deng Y; Zhang D; Ji N; Mukherjee N; Wheeler K; Gupta HB; Padron AS; Kancharla A; Zhang C; Garcia M; Kornepati AVR; Boyman O; Conejo-Garcia JR; Svatek RS; Curiel TJ
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33849925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γδ T cells in cancer: a small population of lymphocytes with big implications.
    Raverdeau M; Cunningham SP; Harmon C; Lynch L
    Clin Transl Immunology; 2019; 8(10):e01080. PubMed ID: 31624593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CD100 receptor interacts with its plexin B2 ligand to regulate epidermal γδ T cell function.
    Witherden DA; Watanabe M; Garijo O; Rieder SE; Sarkisyan G; Cronin SJ; Verdino P; Wilson IA; Kumanogoh A; Kikutani H; Teyton L; Fischer WH; Havran WL
    Immunity; 2012 Aug; 37(2):314-25. PubMed ID: 22902232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma.
    Schönefeldt S; Wais T; Herling M; Mustjoki S; Bekiaris V; Moriggl R; Neubauer HA
    Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptively transferred ex vivo expanded gammadelta-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer.
    Beck BH; Kim HG; Kim H; Samuel S; Liu Z; Shrestha R; Haines H; Zinn K; Lopez RD
    Breast Cancer Res Treat; 2010 Jul; 122(1):135-44. PubMed ID: 19763820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of Vdelta1 gammadelta T cell activation by microbial components.
    Das H; Sugita M; Brenner MB
    J Immunol; 2004 Jun; 172(11):6578-86. PubMed ID: 15153472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distinct MHC-unrestricted immunobiology of innate-like and adaptive-like human γδ T cell subsets-Nature's CAR-T cells.
    Willcox CR; Mohammed F; Willcox BE
    Immunol Rev; 2020 Nov; 298(1):25-46. PubMed ID: 33084045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.